Welcome to the Irish Food Allergy Network


This site is intended as a guide to assist those who, through their work, encounter children and families affected by food allergy.

The site content is intended for use by regulated healthcare professionals.  Its aim is to help in diagnosing and managing suspected food allergy by regulated health care staff in community and hospital settings.  Reproduction of content or referencing IFAN outside of this context requires advance permission, please contact us.

We welcome your feedback and comments.  This site is a work in progress, it will be modified according to feedback received by you-its users.

Privacy and Cookie policy

At IFAN, we have tried to be as transparent as possible about your privacy and use of cookies.  Access our policy in full here

Statement of disclosure

IFAN acknowledges that finance in the form of unrestricted educational support is required in order for its educational and professional aims and objectives to be achieved.

IFAN is grateful for the generous support that has been provided to date by members of industry and pharma as listed here in the contributors’ section, whose disclosure statements are published alongside.

IFAN is committed to best practice with regard to interactions with industry and pharma to ensure that committee member’s professional independence of judgement is not affected by receipt of financial support.

All financial support received by IFAN from industry & pharma is lodged to and managed by IFAN’s unrestricted Education and Development Funds without influence.

Committee members have attended educational meetings funded by commercial enterprises and have received speakers fees. They have/have had complete control over lecture content which is based on evidence based information independent of influence.

IFAN declares that its officers’ and members’ independence of judgement is the basis of its advocacy and educational roles and is not influenced by the financial support received. Any views expressed in IFAN’s literature, website or presentations are sincerely held. If any person identifies any conflict or ambiguity IFAN will address the issue immediately, and will publish any clarifications or alterations required.

December 2018.


Recent News & Articles


Safety information March 23, 2020: Epipen autoinjector devices

It has come to the attention of IFAN that there are potential safety issues as follows: "The FDA in the USA is alerting patients, caregivers and health care professionals that EpiPen 0.3 mg and EpiPen Jr 0.15 mg Auto-Injectors, and the authorized gener

Coronavirus (COVID 19) and Allergy

For all patients at risk of anaphylaxis: -have 2 in-date adrenaline autoinjectors. It's important to be prepared at this time as it can be harder to access GPs and pharmacies. -if in doubt give adrenaline and call an ambulance: EVEN during this publ

Twitter Feed

IFANdotIE @IFANdotIE
IFAN  @IFANdotIE
RT @VenterCarina:Hello allergy moms - do you have a child eating baked milk or baked egg? I would like someone (or a few) to look a… https://t.co/lDeiJWpkxU 
IFAN  @IFANdotIE
Very sad news - Dr William Frankland, allergy scientist pioneer, dies aged 108 https://t.co/vFFXN86qsK 

 
IFAN's publications are endorsed by the Irish Association of Allergy and Immunology and the Irish Nutrition and Dietetic Institute

The information, algorithms and care pathways contained on this site represent the view of IFAN, which was arrived at after careful consideration of the extensive evidence available.

It is the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient.

Material may be freely reproduced for educational and non-profit purposes.

No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of IFAN

In order to improve our service to you please answer this quick survey.